Litcius/Paper detail

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus

Hiroshi Arima, Timothy Cheetham, Mirjam Christ‐Crain, Deborah Cooper, Juliana Drummond, Mark Gurnell, Miles Levy, Ann McCormack, John Newell‐Price, Joseph G. Verbalis, John Wass, The Working Group for Renaming Diabetes Insipidus, Hiroshi Arima, Timothy Cheetham, Mirjam Christ‐Crain, Mark Gurnell, Deborah Cooper, Juliana Drummond, Miles Levy, Mark Gurnell, Ann McCormack, Joseph G. Verbalis, John Newell‐Price, John Wass

2022The Journal of Clinical Endocrinology & Metabolism64 citationsDOIOpen Access PDF

Abstract

Recent data show that patients with a diagnosis of diabetes insipidus (DI) are coming to harm. Here we give the rationale for a name change to arginine vasopressin deficiency and resistance for central and nephrogenic DI, respectively.

Topics & Concepts

Diabetes insipidusNephrogenic diabetes insipidusVasopressinPosition statementMedicineEndocrinologyHarmInternal medicineDiabetes mellitusPsychologyFamily medicineSocial psychologyElectrolyte and hormonal disordersCardiovascular Issues in PregnancyPituitary Gland Disorders and Treatments
Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus | Litcius